Efficacy of Ondansetron in LARS Treatment

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
Patients will be randomized (1:1 ratio) to receive either 4 weeks of Ondansetron followed by 4 weeks of placebo (O-P sequence) or 4 weeks of placebo followed by 4 weeks of Ondansetron (P-O sequence). It will be one week of washout between the two treatments. During the treatment questionnaires will be completed by the patients to evaluate the efficacy of the study treatment and the quality of live.
Epistemonikos ID: ecaffc1f6a409467a62fa270546d64294532dd7d
First added on: May 20, 2024